Form 4: Evolent Health Director Craig Barbarosh Acquires Shares Through Stock Units

Director Craig Barbarosh acquired 7,709 shares of Evolent Health, Inc. through restricted stock units.

Summary

• Craig A. Barbarosh, a director of Evolent Health, Inc., acquired 7,709 shares of Class A Common Stock on June 6, 2024.
• The acquisition was through restricted stock units granted under the company's 2015 Omnibus Incentive Compensation Plan.
• The shares were acquired at a price of $0.
• These shares vest on the earlier of June 6, 2025, or the date of the company's 2025 annual meeting, contingent upon continued service.
• Following the transaction, Mr. Barbarosh directly owns 29,956 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of stock acquisition by a director. It doesn't inherently indicate positive or negative performance.

Positives

• A director increasing their stake in the company can be seen as a positive signal.

Future Outlook

The vesting of the restricted stock units is contingent upon the reporting person's continued service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders.

Key Dates